Accare
11
4
7
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Optimize and Predict Antidepressant Efficacy for Patient With MDD Using Multi-omics Analysis and AI-predictive Tool
Role: collaborator
HANDS-ON: a Personalized, Brief and Intensive Exposure-based Intervention for Youth With Persistent Anxiety or OCD
Role: lead
Brief Behavioral Teacher Training for Behavioral Difficulties
Role: lead
StayFine: Personalised Relapse Prevention of Anxiety and Mood Disorders in Youths
Role: collaborator
First Evaluation of COMET-Y
Role: lead
One Session Virtual Reality During Ongoing Treatment for Anxiety: Feasibility in Children and Adolescents
Role: lead
KOPPeling: Help From Your Own Circle
Role: collaborator
A Randomized Controlled Trial on Brief Behavioral Parent Training
Role: lead
Brief Parent Training for Children With Behavioral Difficulties in Primary Care Settings
Role: lead
Psychosocial ADHD Interventions - Brief Parent Training
Role: lead
Clinical and Cost-effectiveness of Group Schema Therapy for Complex Eating Disorders: the GST-EAT Study
Role: collaborator
All 11 trials loaded